Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

Is West Pharmaceutical Services (WST) Cheap Following Its Recent Run Up? - simplywall.st

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Kiniksa Pharmaceuticals International (KNSA) Beat Sales Expectations, Is It Still 22% Undervalued? - simplywall.st

news.google.com · 12 Sep 2026

Google News – Clinical Trials External News

What FDA’s July 2026 Psychedelic Drug Guidance Actually Says About Trial Design - The Clinical Trial Vanguard

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Syndax Pharmaceuticals (SNDX) Stock May Be Pricey Following A 15% Gain - webull.com

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Amneal Pharmaceuticals (AMRX) After Shelf Filing Has Its Undervalued Case Under Fresh Scrutiny - simplywall.st

news.google.com · 12 Sep 2026

Google News – Biopharma External News

Hydrocarbon Removal Cartridges Market To 2035: Biopharma Demand Drives Growth - News and Statistics - IndexBox

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Precision Trading with Mirum Pharmaceuticals Inc. (MIRM) Risk Zones - news.stocktradersdaily.com

news.google.com · 12 Sep 2026

Google News – Biopharma External News

Experts Call for Deeper Industry-Academia Collaboration to Drive India's Biopharma - Siliconindia

news.google.com · 12 Sep 2026

Google News – Biopharma External News

Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2036 – DelveInsight | Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Lab, Amgen, Teva Pharma, Anne Lindblad - Barchart.com

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - MarketBeat

news.google.com · 12 Sep 2026

Google News – FDA (biotech/pharma) External News

Scholar Rock clinches FDA nod for its SMA therapy after year-long delay - FirstWord Pharma

news.google.com · 12 Sep 2026

Google News – Biopharma External News

Child-Resistant Clasp Closures Market Forecast to 2035: Biopharma Demand Drives 7-9% CAGR - IndexBox

news.google.com · 12 Sep 2026

Google News – FDA (biotech/pharma) External News

Scholar Rock wins FDA approval for first drug to target SMA muscle loss - STAT

news.google.com · 12 Sep 2026

Google News – Pharmaceuticals External News

Olema Pharmaceuticals (OLMA) Shares Drop 15% After AstraZeneca B - GuruFocus

news.google.com · 12 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Is West Pharmaceutical Services (WST) Cheap Following Its Recent Run Up? - simplywall.st

Kiniksa Pharmaceuticals International (KNSA) Beat Sales Expectations, Is It Still 22% Undervalued? - simplywall.st

What FDA’s July 2026 Psychedelic Drug Guidance Actually Says About Trial Design - The Clinical Trial Vanguard

Syndax Pharmaceuticals (SNDX) Stock May Be Pricey Following A 15% Gain - webull.com

Amneal Pharmaceuticals (AMRX) After Shelf Filing Has Its Undervalued Case Under Fresh Scrutiny - simplywall.st

Hydrocarbon Removal Cartridges Market To 2035: Biopharma Demand Drives Growth - News and Statistics - IndexBox

Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat

Precision Trading with Mirum Pharmaceuticals Inc. (MIRM) Risk Zones - news.stocktradersdaily.com

Experts Call for Deeper Industry-Academia Collaboration to Drive India's Biopharma - Siliconindia

Migraine Market: Pharma Pipeline Fuels Rapid Expansion by 2036 – DelveInsight | Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Lab, Amgen, Teva Pharma, Anne Lindblad - Barchart.com

Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears - MarketBeat

Scholar Rock clinches FDA nod for its SMA therapy after year-long delay - FirstWord Pharma

Child-Resistant Clasp Closures Market Forecast to 2035: Biopharma Demand Drives 7-9% CAGR - IndexBox

Scholar Rock wins FDA approval for first drug to target SMA muscle loss - STAT

Olema Pharmaceuticals (OLMA) Shares Drop 15% After AstraZeneca B - GuruFocus